Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.00
-0.53 (-1.25%)
Mar 5, 2026, 4:00 PM EST - Market closed
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $4.57 billion as of March 6, 2026. Its market cap has increased by 1,183.59% in one year.
Market Cap
4.57B
Enterprise Value
4.27B
1-Year Change
1,183.59%
Ranking
Category
Stock Price
$42.00
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $4.57B, an increase of 3,080.98%. That is a compound annual growth rate of 97.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 4.57B | 3.96% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.11B |
| Celcuity | 4.96B |
| Apogee Therapeutics | 4.69B |
| Scholar Rock Holding | 4.52B |
| Amicus Therapeutics | 4.51B |
| Structure Therapeutics | 4.47B |
| Erasca | 4.37B |
| TG Therapeutics | 4.26B |